Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus type 1 p13II accessory proteins interact with farnesyl pyrophosphate synthetase

Journal of Virology

Volumn 76, Issue 3, 2002, Pages 1400-1414

  Lefèbvre, Laurent ^a   Vanderplasschen, Alain ^a   Ciminale, Vincenzo ^a   Heremans, Hubertine ^a   Dangoisse, Olivier ^a   Jauniaux, Jean Claude ^a   Toussaint, Jean François ^a   Zelnik, Vlado ^a   Burny, Arsène ^a   Kettmann, Richard ^a   Willems, Luc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GERANYLTRANSFERASE; GLUTATHIONE TRANSFERASE; VIRUS PROTEIN;

ALPHA HELIX; ARTICLE; BOVINE LEUKEMIA VIRUS; CARCINOGENICITY; CELL ASSAY; HUMAN T CELL LEUKEMIA VIRUS; IN VITRO STUDY; MITOCHONDRION; NONHUMAN; ONCOVIRINAE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RETICULOCYTE; RETROVIRUS; VIRUS REPLICATION;

EID: 0036149353     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.3.1400-1414.2002     Document Type: Article

References (56)

1. I is required for efficient viral infectivity in primary lymphocytes
2. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus
3. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo
4. Ras and leukemia: From basic mechanisms to gene-directed therapy
5. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers
6. Differential expression of alternatively spliced pX mRNAs in HTLV-1-infected cell lines
7. Antibody reactivities to tumor-suppressor protein p53 and HTLV-1 Tof, Rex and Tax in HTLV-1-infected people with differing clinical status
8. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I
9. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II
10. Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II
11. II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-1)
12. I reduces viral infectivity in vivo
13. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression
14. The human T-cell lymphotropic virus type 1 T of protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex
15. The HTLV-1 OrfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits
16. X-I and X-II open reading frames of HTLV-1 are not required for virus replication or for immortalization of primary T-cells in vitro
17. Mitochondria as the central control point of apoptosis
18. I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase
19. Enzymology and biology of CaaX protein prenylation
20. Human T-cell leukemia virus type II nucleotide sequences between env and the last exon of tax/rex are not required for viral replication or cellular transformation
21. Differential binding of proteins to peroxisomes in rat hepatoma cells: Unique association of enzymes involved in isoprenoid metabolism
22. II interacts with cellular proteins
23. The MHC class I heavy chain is a common target of the small proteins encoded by the 3′ end of HTLV type 1 and HTLV type 2
24. Effect of site-directed mutagenesis of conserved aspartate and arginine residues upon farnesyl diphosphate synthase activity
25. Mechanism of aminobisphosphonate action: Characterization of alendronate inhibition of the isoprenoid pathway
26. In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein
27. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I
28. II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments
29. I and the vacuolar H+-ATPase 16 kDa subunit protein
30. Farnesyl-diphosphate synthase is localized in peroxisomes
31. Dexamethasone-induced decrease in HMG-CoA reductase protein-farnesyl transferase activities does not impair ras processing in AR 4-2J cells
32. Effects of site-directed mutagenesis of the highly conserved aspartate residues in domain II of farnesyl diphosphate synthase activity
33. Lovastatin inhibits tumor growth and metastasis development of rat fibrosarcoma
34. I proteins bind the interleukin-2 receptor β and γc chains and affects their expression on the cell surface
35. Conversion from archaeal geranylgeranyl diphosphate synthase to farnesyl diphosphate synthase
36. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides
37. The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis
38. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes
39. + T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone
40. The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes
41. Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development
42. Isoprenoid biosynthesis in rat liver mitochondria. Studies on farnesyl pyrophosphate synthase and trans-prenyltransferase
43. Complete nucleotide sequence of the genome of bovine leukemia virus: Its evolutionary relationship to other retroviruses
44. Novel anti-cancer agents in development: Exciting prospects and new challenges
45. Yeast farnesyl-diphosphate synthase: Site-directed mutagenesis of residues in highly conserved prenyltransferase domains I and II
46. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1
47. Crystal structure of recombinant farnesyl diphosphate synthase at 2.6-Å resolution
48. I protein greatly influences its stability
49. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function
50. Cooperation between bovine leukemia virus transactivator protein and Ha-ras oncogene product in cellular transformation
51. In vivo infection of sheep by bovine leukemia virus mutants
52. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames
53. Bovine leukemia virus as a model for human T-cell leukemia virus
54. Genetic determinants of bovine leukemia virus pathogenesis
55. II functions as a transcription factor and differentially modulates CREB-responsive promoters